financial results
Burning Rock Biotech Q1 Revenues up 5 Percent
The company saw continued shrinkage in its central laboratory business due to the COVID-19 pandemic in January coupled with significant growth in pharma services.
Agilent Technologies Fiscal Q2 Revenues Rise 7 Percent as Firm Lowers 2023 Guidance
Diagnostics and Genomics Group revenues were up 1 percent year over year, growing less than revenues for the company's other two business segments.
T2 Biosystems Lays off 30 Percent of Workforce as Q1 Revenues Drop 71 Percent
The company also announced that it has submitted its T2Biothreat Panel to the US Food and Drug Administration for 510(k) clearance.
LumiraDx Q1 Revenues Fall 82 Percent but Beat Wall Street Estimate
The company's SARS-CoV-2 antigen test strips accounted for $10.6 million of revenues while its Fast Lab Solutions business contributed $4.3 million.
SomaLogic Q1 Revenues Fall 11 Percent but Beat Wall Street Consensus
Six weeks after a management shakeup, the proteomics firm is looking for unspecified "inorganic" opportunities to become profitable.